Search Results - "Friend, J Woodrow"

Imatinib reverses doxorubicin resistance by affecting activation of STAT3-dependent NF-κB and HSP27/p38/AKT pathways and by inhibiting ABCB1 by Sims, Jonathan T, Ganguly, Sourik S, Bennett, Holly, Friend, J Woodrow, Tepe, Jessica, Plattner, Rina

“…Despite advances in cancer detection and prevention, a diagnosis of metastatic disease remains a death sentence due to the fact that many cancers are either…”
Get full text

c-Abl and Arg are activated in human primary melanomas, promote melanoma cell invasion via distinct pathways, and drive metastatic progression by Ganguly, S S, Fiore, L S, Sims, J T, Friend, J W, Srinivasan, D, Thacker, M A, Cibull, M L, Wang, C, Novak, M, Kaetzel, D M, Plattner, R

“…Despite 35 years of clinical trials, there is little improvement in 1-year survival rates for patients with metastatic melanoma, and the disease is essentially…”
Get full text

Imatinib Reverses Doxorubicin Resistance by Affecting Activation of STAT3-Dependent NF-[kappa]B and HSP27/p38/AKT Pathways and by Inhibiting ABCB1 by Sims, Jonathan T, Ganguly, Sourik S, Bennett, Holly, Friend, J. Woodrow, Tepe, Jessica, Plattner, Rina

“…Despite advances in cancer detection and prevention, a diagnosis of metastatic disease remains a death sentence due to the fact that many cancers are either…”
Get full text

Abstract C51: c-Abl and Arg are activated in human primary melanomas, promote melanoma cell invasion, proliferation, survival, and drive metastatic progression by Ganguly, Sourik S., Fiore, Leann S., Sims, Jonathan T., Friend, J Woodrow, Srinivasan, DivyaMani, Thacker, Matthew, Cibull, Michael L., Chi, Wang, Plattner, Rina

“…Abstract Despite 40 years of clinical trials, there has been little improvement in one-year survival rates for patients with metastatic melanoma, and the…”
Get full text